Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Adult group in immunogenicity and safety study of combined immunization
Sinovac Research and Development Co.,
COVID-19
1 trial -
Aerosolized 13 cis retinoic acid plus Vitamin D
The First People's Hospital of Lianyungang
Post COVID-19 Anosmia (Loss of Smell)
1 trial -
Azvudine
The First People's Hospital of Lianyungang
COVID-19
1 trial -
BIMERVAX LP.8.1 emulsion for injection COVID... for COVID-19 infection
The George Institute
COVID-19 infection
1 trial -
COVAX
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
COVID-19 Vaccine (Vero cell), Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Covid-19 vaccine (0-1-4 schedule)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
2 trials -
Experimental Group
Sinovac Research and Development Co.,
COVID-19
4 trials -
Experimental vaccine 1
Sinovac Research and Development Co.,
COVID-19
1 trial -
HIPRA-HH-17
Hipra Human Health S.L.
COVID-19
1 trial -
High-dosage SARS-CoV-2 vaccine
Sinovac Research and Development Co.,
COVID-19
1 trial -
Inactivated COVID-19 vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
Sinovac Research and Development Co.,
COVID-19
1 trial -
Inactivated SARS-CoV-2 Vaccine (Vero cell）
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-QINF-4001
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-4010
Sinovac Research and Development Co.,
COVID-19
1 trial -
Pfizer-BioNTech mRNA COVID-19 vaccine
BRIGHT MINDS BIOSCIENCES INC.
COVID -19
1 trial -
Renoir
The George Institute
Covid-19 infection
1 trial -
SARS-CoV-2 Inactivated Vaccine
Sinovac Research and Development Co.,
COVID-19
2 trials -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
COVID Convalescent Plasma
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Favipiravir
The First People's Hospital of Lianyungang
COVID-19
1 trial -
Nitazoxanide Tablets
Vera Therapeutics
COVID-19
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.